CCR4 as a Therapeutic Target for Cancer Immunotherapy
CCR4 is a chemokine receptor mainly expressed by T cells. It is the receptor for two CC chemokine ligands, CCL17 and CCL22. Originally, the expression of CCR4 was described as highly selective for helper T type 2 (Th2) cells. Later, its expression was extended to other T cell subsets such as regulat...
Guardado en:
Autor principal: | Osamu Yoshie |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/97b407ee681944ee986b13dae52be6d5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Expression of the Chemokine Receptor CCR7 in the Normal Adrenal Gland and Adrenal Tumors and Its Correlation with Clinical Outcome in Adrenocortical Carcinoma
por: Carmina Teresa Fuss, et al.
Publicado: (2021) -
CHEMOKINE RECEPTORS AT DISTINCT DIFFERENTIATION STAGES OF T-HELPERS FROM PERIPHERAL BLOOD
por: I. V. Kudryavtsev, et al.
Publicado: (2016) -
Expression of resistin, CXCR3, IP-10, CCR5 and MIP-1α in obese patients with different severity of asthma
por: Rojas-Dotor,Sara, et al.
Publicado: (2013) -
CCR6 Deficiency Increases Infarct Size after Murine Acute Myocardial Infarction
por: David Schumacher, et al.
Publicado: (2021) -
Gastric and colon metastasis from breast cancer: case report, review of the literature, and possible underlying mechanisms
por: Villa Guzmán JC, et al.
Publicado: (2016)